Depression after childbirth affects about one in 10 women. This type of depression has a great impact on the mother, but can also affect the development of the child. It is therefore important to identify possible depression at an early…
Read More
Nursing graduate students report high levels of stress, anxiety, depression
Researchers at the University of Colorado College of Nursing have found that nearly one-quarter of graduate nursing students have reported elevated levels of stress, anxiety and depression, compounded in the past year by the COVID-19 pandemic. Study findings, published recently…
Read More
Cognitive behavioral therapy can reduce stress, improve mood in pregnant women
Perinatal depression has soared during the pandemic. But many mental health professionals are overwhelmed and can't take on new clients. Good news comes from a new Northwestern Medicine study finding paraprofessionals generated similar reductions in depressive symptoms as mental health…
Read More
UNH receives $2.97 million in grants to investigate the effectiveness of wilderness therapy
The University of New Hampshire’s Outdoor Behavioral Healthcare Center receives $2.97 million in grants to conduct a first-of-its-kind randomized study looking at the effectiveness of outdoor behavioral health (OBH), or wilderness therapy, a prescriptive treatment for teens struggling with depression,…
Read More
Adverse Mental Health Symptoms Related to COVID-19 Remained High 6 Months Into Pandemic
(Reuters Health) – As of September 2020, the prevalence of adverse mental health symptoms remained high among Americans, a new survey finds. Rates of suicidal ideation, substance abuse, and symptoms of depression and anxiety in August and September were elevated…
Read More
Zocor (MK)
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. ZOCOR® Simvastatin Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about ZOCOR.It does not contain all the available information. It does…
Read More
Sudafed Sinus 12 Hour Relief Tablets
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. SUDAFED® SINUS 12 HOUR RELIEF TABLETS Pseudoephedrine hydrochloride Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about SUDAFED® Sinus 12 Hour…
Read More
Aprepitant APOTEX
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. APREPITANT APOTEX aprepitant Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about this medicine. It does not contain all the available…
Read More
Naprosyn SR
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. NAPROSYN SR® pronounced nap-row-sin S-R contains the active ingredient naproxen Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about NAPROSYN SR…
Read More
Estalis Continuous
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. ESTALIS® CONTINUOUS estradiol / norethisterone acetate (NETA) Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about the menopause (the “change of…
Read More